Luly Jay R. (CIK 0001571211)

Latest company ownership

Shares held
862,769
Last filed at
Dec 5, 2025
Confidence Score
47.8
2025Q4
Confidence Score History
2014Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 5, 2025 Dec 5, 2025 ENANTA PHARMACEUTICALS INC CEO Sell 45.0 -4,743 -0.55% ✗ $67.5K
Dec 1, 2025 Dec 3, 2025 ENANTA PHARMACEUTICALS INC CEO Sell 51.3 -1,885 -0.22% ✗ $26.6K
Feb 12, 2025 Feb 14, 2025 ENANTA PHARMACEUTICALS INC CEO Sell 78.8 +18,016 2.13% ✗ $41.8K
Feb 12, 2025 Feb 12, 2025 ENANTA PHARMACEUTICALS INC CEO Buy 92.5 +45,000 5.61% ✗ $256.1K
Dec 6, 2024 Dec 10, 2024 ENANTA PHARMACEUTICALS INC CEO Sell 48.8 -5,142 -0.64% ✗ $41.4K
Dec 1, 2024 Dec 3, 2024 ENANTA PHARMACEUTICALS INC CEO Sell 51.3 -3,829 -0.47% ✗ $32.9K
Feb 12, 2024 Feb 14, 2024 ENANTA PHARMACEUTICALS INC CEO Sell 61.3 +3,816 0.47% ✗ $19.7K
Dec 5, 2023 Dec 6, 2023 ENANTA PHARMACEUTICALS INC CEO Sell 45.0 -7,230 -0.89% ✗ $69.6K
Dec 1, 2023 Dec 5, 2023 ENANTA PHARMACEUTICALS INC CEO Sell 45.0 -5,787 -0.71% ✗ $54.9K
Mar 13, 2023 Mar 14, 2023 ENANTA PHARMACEUTICALS INC CEO Sell 32.5 -27,912 -3.29% ✓ $1.3M
Feb 13, 2023 Feb 15, 2023 ENANTA PHARMACEUTICALS INC CEO Sell 92.5 +31,505 4.00% ✗ $1.1M
Feb 13, 2023 Feb 15, 2023 ENANTA PHARMACEUTICALS INC CEO Sell 87.5 +10,914 1.38% ✗ $1.1M
Dec 16, 2022 Dec 16, 2022 ENANTA PHARMACEUTICALS INC CEO Sell 32.5 -30,000 -3.73% ✓ $1.3M
Dec 1, 2022 Dec 5, 2022 ENANTA PHARMACEUTICALS INC CEO Sell 42.5 -5,659 -0.73% ✗ $250.9K
Feb 14, 2022 Feb 15, 2022 ENANTA PHARMACEUTICALS INC CEO Sell 72.5 +5,673 0.80% ✗ $147.2K
Dec 1, 2021 Dec 3, 2021 ENANTA PHARMACEUTICALS INC CEO Sell 47.5 -1,944 -0.28% ✗ $170.4K
Sep 15, 2021 Sep 17, 2021 ENANTA PHARMACEUTICALS INC CEO Sell 45.0 -4,516 -0.66% ✓ $266.7K
Dec 15, 2020 Dec 16, 2020 ENANTA PHARMACEUTICALS INC CEO Sell 47.5 -2,201 -0.32% ✗ $93.6K
Feb 12, 2020 Feb 18, 2020 ENANTA PHARMACEUTICALS INC CEO Sell 82.5 +7,273 1.13% ✗ $164.7K
Dec 16, 2019 Jan 6, 2020 ENANTA PHARMACEUTICALS INC CEO Sell 45.0 -3,330 -0.52% ✗ $212.7K
Feb 12, 2019 Feb 13, 2019 ENANTA PHARMACEUTICALS INC CEO Sell 92.5 +29,670 4.93% ✗ $1.8M
Jul 5, 2018 Jul 9, 2018 ENANTA PHARMACEUTICALS INC CEO Sell 27.5 -35,000 -5.57% ✓ $4.4M
May 16, 2018 May 18, 2018 ENANTA PHARMACEUTICALS INC CEO Sell 32.5 -25,000 -3.83% ✓ $2.6M
Feb 12, 2018 Feb 13, 2018 ENANTA PHARMACEUTICALS INC CEO Sell 90.0 +18,205 2.87% ✗ $855.4K
Feb 13, 2017 Feb 15, 2017 ENANTA PHARMACEUTICALS INC CEO Sell 72.5 +4,522 0.72% ✗ $67.9K
Mar 9, 2015 Mar 10, 2015 ENANTA PHARMACEUTICALS INC CEO Sell 35.0 -15,000 -3.05% ✓ $500.5K
Feb 20, 2015 Feb 20, 2015 ENANTA PHARMACEUTICALS INC CEO Sell 38.8 -15,000 -2.96% ✓ $530.3K
Jan 5, 2015 Jan 6, 2015 ENANTA PHARMACEUTICALS INC CEO Sell 38.8 -15,000 -2.88% ✓ $756.5K
Dec 1, 2014 Dec 2, 2014 ENANTA PHARMACEUTICALS INC CEO Sell 38.8 -15,000 -2.83% ✓ $680.8K
Nov 3, 2014 Nov 4, 2014 ENANTA PHARMACEUTICALS INC CEO Sell 38.8 -15,000 -2.76% ✓ $637.8K
Apr 1, 2014 Apr 2, 2014 ENANTA PHARMACEUTICALS INC CEO Sell 38.8 -15,000 -2.68% ✓ $587.5K
Mar 10, 2014 Mar 12, 2014 ENANTA PHARMACEUTICALS INC CEO Sell 42.5 -10,000 -1.76% ✓ $384.9K
Feb 14, 2014 Feb 14, 2014 ENANTA PHARMACEUTICALS INC CEO Sell 45.0 -5,800 -1.01% ✓ $221K
Jan 2, 2014 Jan 3, 2014 ENANTA PHARMACEUTICALS INC CEO Sell 45.0 -5,800 -1.76% ✓ $162.7K